Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 985345, 7 pages
http://dx.doi.org/10.1093/ecam/nep102
Original Article

Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract

1State University of New York (SUNY), Albany, NY, USA
2Advanced Restoration Technologies, Inc., 9035 North 15th Place, Phoenix, AZ 85020, USA

Received 29 December 2008; Accepted 8 July 2009

Copyright © 2011 Sridar Chittur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Délos, C. Iehlé, P. M. Martin, and J. Raynaud, “Inhibition of the activity of ‘basic’ 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 48, pp. 347–352, 1994. View at Google Scholar
  2. E. Stoner, “The clinical effects of a 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia,” Journal of Urology, vol. 147, no. 5, pp. 1298–1302, 1992. View at Google Scholar
  3. P. Ekman, “Pharmacological treatment of benign prostatic hyperplasia with Finasteride: a clinical review,” Archivos Espanoles de Urologia, vol. 47, no. 9, pp. 883–888, 1994. View at Google Scholar
  4. E. Koch, “Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms,” Planta Medica, vol. 67, pp. 489–500, 2001. View at Google Scholar
  5. G. L. Plosker and R. N. Brogden, “Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia,” Drugs and Aging, vol. 9, no. 5, pp. 379–395, 1996. View at Google Scholar
  6. K. D. Kaufman and R. P. Dawber, “Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia,” Expert Opinion on Investigational Drugs, vol. 8, no. 4, pp. 403–415, 1999. View at Google Scholar
  7. K. D. Kaufman, E. A. Olsen, D. Whiting et al., “Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group,” Journal of the American Academy of Dermatology, vol. 39, pp. 578–589, 1998. View at Google Scholar
  8. N. Prager, K. Bickett, N. French, and G. Marcovici, “A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-α-reductase in the treatment of androgenetic alopecia,” Journal of Alternative and Complementary Medicine, vol. 8, no. 2, pp. 143–152, 2002. View at Google Scholar
  9. R. M. Trüeb, “Association between smoking and hair loss: another opportunity for health education against smoking?” Dermatology, vol. 206, pp. 189–191, 2003. View at Google Scholar
  10. A. Descazeaud, M. A. Rubin, M. Hofer et al., “BPH gene expression profile associated to prostate gland volume,” Diagnostic Molecular Pathology, vol. 17, no. 4, pp. 207–213, 2008. View at Publisher · View at Google Scholar · View at PubMed
  11. R. M. Trüeb, “Molecular mechanisms of androgenetic alopecia,” Experimental Gerontology, vol. 37, no. 8-9, pp. 981–990, 2002. View at Publisher · View at Google Scholar
  12. P. Hirsso, U. Rajala, L. Hiltunen, J. Jokelainen, S. Keinänen-Kiukaanniemi, and S. Näyhä, “Obesity and low-grade inflammation among young finnish men with early-onset alopecia,” Dermatology, vol. 214, no. 2, pp. 125–129, 2007. View at Publisher · View at Google Scholar · View at PubMed
  13. K. A. Greco and K. T. McVary, “The role of combination medical therapy in benign prostatic hyperplasia,” International Journal of Impotence Research, vol. 20, no. 3, pp. S33–S43, 2008. View at Publisher · View at Google Scholar · View at PubMed
  14. K. T. McVary, “A review of combination therapy in patients with benign prostatic hyperplasia,” Clinical Therapeutics, vol. 29, no. 3, pp. 387–398, 2007. View at Publisher · View at Google Scholar
  15. F. D. Khan, S. Roychowdhury, R. Nemes, P. M. Vyas, P. M. Woster, and C. K. Svensson, “Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes,” Toxicology, vol. 218, no. 2-3, pp. 90–99, 2006. View at Publisher · View at Google Scholar · View at PubMed
  16. S. Huh, J. Lee, E. Jung et al., “A cell-based system for screening hair growth-promoting agents,” Archives of Dermatological Research, vol. 301, no. 5, pp. 381–385, 2009. View at Publisher · View at Google Scholar · View at PubMed
  17. R. Moeller, J. Lichter, and B. Blömeke, “Impact of para-phenylenediamine on cyclooxygenases expression and prostaglandin formation in human immortalized keratinocytes (HaCaT),” Toxicology, vol. 249, no. 2-3, pp. 167–175, 2008. View at Publisher · View at Google Scholar · View at PubMed
  18. H. G. Yoo, I.-Y. Chang, H. K. Pyo et al., “The additive effects of minoxidil and retinol on human hair growth in vitro,” Biological and Pharmaceutical Bulletin, vol. 30, no. 1, pp. 21–26, 2007. View at Publisher · View at Google Scholar
  19. S.-S. Rho, S.-J. Park, S.-L. Hwang et al., “The hair growth promoting effect of Asiasari radix extract and its molecular regulation,” Journal of Dermatological Science, vol. 38, no. 2, pp. 89–97, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. P. Chavan, K. Joshi, and B. Patwardhan, “DNA microarrays in herbal drug research,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 4, pp. 447–457, 2006. View at Publisher · View at Google Scholar · View at PubMed
  21. H. Kobayashi, M. Ishii, S. Takeuchi et al., “Efficacy and safety of a traditional herbal medicine, Hochu-ekki-to in the long-term management of Kikyo (Delicate Constitution) patients with atopic dermatitis: a 6-month, multicenter, double-blind, randomized, placebo-controlled study,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 3, pp. 367–373, 2010. View at Google Scholar
  22. J. W. Cho, C. W. Kim, and K. S. Lee, “Modification of gene expression by melatonin in UVB-irradiated HaCaT keratinocyte cell lines using a cDNA microarray,” Oncology Reports, vol. 17, no. 3, pp. 573–577, 2007. View at Google Scholar
  23. K. M. Lee, J. G. Lee, E. Y. Seo et al., “Analysis of genes responding to ultraviolet B irradiation of HaCaT keratinocytes using a cDNA microarray,” British Journal of Dermatology, vol. 152, no. 1, pp. 52–59, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. M. A. Dayem, C. Moreilhon, L. Turchi et al., “Early gene expression in wounded human keratinocytes revealed by DNA microarray analysis,” Comparative and Functional Genomics, vol. 4, no. 1, pp. 47–55, 2003. View at Publisher · View at Google Scholar · View at PubMed
  25. C. Watkins, A. McKellar, K. Jensen et al., “Development and validation of an oligonucleotide microarray for immuno-inflammatory genes of ruminants,” Veterinary Research Communications, vol. 32, no. 8, pp. 647–657, 2008. View at Publisher · View at Google Scholar · View at PubMed
  26. L. A. Begley, S. Kasina, J. MacDonald, and J. A. Macoska, “The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy,” Cytokine, vol. 43, no. 2, pp. 194–199, 2008. View at Publisher · View at Google Scholar · View at PubMed
  27. B. Homey, S. Meller, T. Savinko, H. Alenius, and A. Lauerma, “Modulation of chemokines by staphylococcal superantigen in atopic dermatitis,” Chemical Immunology and Allergy, vol. 93, no. 1, pp. 181–194, 2007. View at Publisher · View at Google Scholar · View at PubMed
  28. N. N. Kristensen, D. Brudzewsky, M. Gad, and M. H. Claesson, “Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells,” Inflammatory Bowel Diseases, vol. 12, no. 7, pp. 612–618, 2006. View at Publisher · View at Google Scholar · View at PubMed
  29. G. Zoumpopoulou, E. Tsakalidou, J. Dewulf, B. Pot, and C. Grangette, “Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model,” International Journal of Food Microbiology, vol. 131, no. 1, pp. 40–51, 2009. View at Publisher · View at Google Scholar · View at PubMed
  30. T. Alestas, R. Ganceviciene, S. Fimmel, K. Müller-Decker, and C. C. Zouboulis, “Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands,” Journal of Molecular Medicine, vol. 84, pp. 75–87, 2006. View at Google Scholar
  31. P. Libby, “Role of inflammation in atherosclerosis associated with rheumatoid arthritis,” American Journal of Medicine, vol. 121, no. 10, pp. S21–S31, 2008. View at Publisher · View at Google Scholar · View at PubMed
  32. C. R. Thornfeldt, “Chronic inflammation is etiology of extrinsic aging,” Journal of Cosmetic Dermatology, vol. 7, no. 1, pp. 78–82, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. R. Rückert, G. Lindner, S. Bulfone-Paus, and R. Paus, “High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo,” British Journal of Dermatology, vol. 143, pp. 1036–1039, 2000. View at Google Scholar
  34. P. C. Arck, B. Handjiski, E. M. Peters et al., “Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways,” American Journal of Pathology, vol. 162, pp. 803–814, 2003. View at Google Scholar
  35. Y. F. Mahé, B. Buan, N. Billoni et al., “Pro-inflammatory cytokine cascade in human plucked hair,” Skin Pharmacology, vol. 9, no. 6, pp. 366–375, 1996. View at Google Scholar
  36. M. Inazu and T. Matsumiya, “Physiological functions of carnitine and carnitine transporters in the central nervous system,” Nihon Shinkei, Seishin, Yakurigaku Zasshi, vol. 28, pp. 113–120, 2008. View at Google Scholar
  37. A. A. Spasov and I. N. IIezhitsa, “Stereopharmacology of carnitine,” Ross Fiziol Zh Im I M Sechenova, vol. 91, no. 12, pp. 1469–1480, 2005. View at Google Scholar
  38. M. Janson, “Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging,” Clinical Interventions in Aging, vol. 1, no. 3, pp. 261–265, 2006. View at Publisher · View at Google Scholar
  39. K. Foitzik, E. Hoting, T. Förster, P. Pertile, and R. Paus, “L-Carnitine-L-tartrate promotes human hair growth in vitro,” Experimental Dermatology, vol. 16, no. 11, pp. 936–945, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. G. R. Seaman, “Role of thioctic acid in the transfer of acyl groups,” Proceedings of the Society for Experimental Biology and Medicine, vol. 82, pp. 184–189, 1953. View at Google Scholar
  41. S. Salinthone, V. Yadav, DN Bourdette, and D. W. Carr, “Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS,” Endocrine, Metabolic & Immune Disorders—Drug Targets, vol. 8, pp. 132–142, 2008. View at Google Scholar
  42. A. C. Buck, “Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action,” The Journal of Urology, vol. 172, pp. 1792–1799, 2004. View at Google Scholar
  43. F. K. Habib, M. Ross, C. K. Ho, V. Lyons, and K. Chapman, “Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression,” International Journal of Cancer, vol. 114, pp. 190–194, 2005. View at Google Scholar
  44. J. F. Libecco and W. F. Bergfeld, “Finasteride in the treatment of alopecia,” Expert Opinion on Pharmacotherapy, vol. 5, no. 4, pp. 933–940, 2004. View at Publisher · View at Google Scholar · View at PubMed
  45. B. Havlickova and M. Friedrich, “The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses,” Mycoses, vol. 51, supplement 4, pp. 16–26, 2008. View at Publisher · View at Google Scholar · View at PubMed
  46. Ó. González-Pérez, N. A. Moy-López, and J. Guzmán-Muñiz, “Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine,” Revista de Investigacion Clinica, vol. 60, no. 1, pp. 58–67, 2008. View at Google Scholar
  47. S. Kumaran, S. Savitha, M. Anusuya Devi, and C. Panneerselvam, “L-carnitine and DL-α-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues,” Mechanisms of Ageing and Development, vol. 125, no. 7, pp. 507–512, 2004. View at Publisher · View at Google Scholar · View at PubMed